Drug Search Results
More Filters [+]

Phendimetrazine

Alternative Names: phendimetrazine, sprx-105, melfiat-105, bontril, phenazine, x-trozine l.a., sprx-3, cam-metrazine, adphen, alphazine, x-trozine, phenazine-35, plegine, metra, statobex, di-metrex, melfiat, statobex-g, bontril pdm, fendique er
Latest Update: 2024-07-25
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: ADRA1A Agonist,ADRA1B Agonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: N/A

FDA Designation: None *

Approval Status: Approved

Approved Countries: Bangladesh | India | Italy | Korea | Pakistan | United States

Approved Indications: None

Known Adverse Events: None

Company: None
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Phendimetrazine

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Recent News Events

Date

Type

Title